Skip to main content
Log in

Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Morton A (2017) A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria? Osteoporos Int. doi:10.1007/s00198-017-3922-6

    PubMed  Google Scholar 

  2. Dede AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, Dontas I, Papaioannou N, Tournis S (2016) Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 27:3409–3425. doi:10.1007/s00198-016-3719-z

    Article  CAS  Google Scholar 

  3. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, Brasure M, Kane RL, Ouellette J, Monga M (2013) Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med 158(7):535–543. doi:10.7326/0003-4819-158-7-201304020-00005

    Article  PubMed  Google Scholar 

  4. Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 18(4):479–486

    Article  CAS  PubMed  Google Scholar 

  5. Arrabal-Polo MA, Arias-Santiago S, de Haro-Muñoz T, Lopez-Ruiz A, Orgaz-Molina J, Gonzalez-Torres S, Zuluaga-Gomez A, Arrabal-Martin M (2013) Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis. Urology 81(4):731–737. doi:10.1016/j.urology.2012.12.013

    Article  PubMed  Google Scholar 

  6. García-Nieto V, Monge-Zamorano M, González-García M, Luis-Yanes MI (2012) Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria. Pediatr Nephrol 27(2):261–268. doi:10.1007/s00467-011-1987-6

    Article  PubMed  Google Scholar 

  7. Kruse C, Eiken P, Vestergaard P (2016) Continuous and long-term treatment is more important than dosage for the protective effect of thiazide use on bone metabolism and fracture risk. J Intern Med 279(1):110–122. doi:10.1111/joim.12397

    Article  CAS  PubMed  Google Scholar 

  8. Kruse C, Eiken P, Vestergaard P (2016) Optimal age of commencing and discontinuing thiazide therapy to protect against fractures. Osteoporos Int 27(5):1875–1885. doi:10.1007/s00198-015-3451-0

    Article  CAS  PubMed  Google Scholar 

  9. Aung K, Htay T (2011) Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev 10:CD005185. doi:10.1002/14651858.CD005185.pub2

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. D. Dede.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dede, A.D., Trovas, G., Chronopoulos, E. et al. Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?. Osteoporos Int 28, 1761–1762 (2017). https://doi.org/10.1007/s00198-017-3927-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-017-3927-1

Keywords

Navigation